Fulcrum Therapeutics (FULC) Q2 2024 Earnings

13MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.44
-0.42
-0.4
-0.38

Details

Expected EPS
-0.4375
Actual EPS
-0.43
Surprise EPS
0.01
Surprise Percent
+1.71%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.43 per share for Q2 2024.

0 Comments

Share your thoughts